Create Profile

Creating your profile will enable you to submit photos and stories to get published on News24.

Please provide a username for your profile page:

This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire 24.com network.

Facebook Sign-In

Hi News addict,

Join the News24 Community to be involved in breaking the news.

Log in with Facebook to comment and personalise news, weather and listings.


As Ebola disappears, no useful data seen from vaccine trials

12 May 2015, 20:26

Geneva - With Ebola nearly stamped out in West Africa, vaccine trials will probably fail to provide enough useful data on how well they protect people against the deadly virus, the World Health Organization (WHO) said on Tuesday.

Liberia was declared free from Ebola by the government and the WHO on Saturday after 42 days without a new case of the virus, which killed more than 4,700 people there during a year-long epidemic.

Also read: Experts denounce WHO's slow Ebola response

Guinea reported seven cases in the week of May 4-10, while Sierra Leone had two, Dr. Marie-Paule Kieny, WHO Assistant Director-General for Health Systems and Innovation, told a news briefing in Geneva.

"The best news is we are going to zero cases, there is absolutely no doubt about that," she said.

But two experimental Ebola vaccines, developed by GlaxoSmithKline and jointly by Merck and NewLink Genetics, being tested on volunteers may not yield sufficient data on efficacy as case numbers fall, Kieny said.

"It is not clear whether it will be possible to have even a hint of efficacy from these two vaccines," she said, noting that they already had been proven safe.

"To have efficacy we must see if people are actually protected, as the number of cases is going down it is not clear whether there will be a strong robust answer to this question at the end of epidemic," she said.

Two drugs, Zmapp made by Zmapp Pharmaceuticals and sIRNA by Tekmira Pharmaceuticals, are also being tested and it is hoped that they will produce some limited results on efficacy, Kieny said.

The U.N. agency this week hosted a two-day experts' meeting on Ebola research and development after the world's largest epidemic that has killed more than 11,000 since December 2013. The aim is to draw up a plan to speedily develop vaccines and drugs for use in clinical trials during any future outbreak of any infectious disease.

Consultations will be held in coming months on issues including developing protocols, data sharing and storing biological material including the virus and blood serum of patients, Kieny said.

Asked when a framework deal on research and development could be reached, she said: "Tentatively we try to go for the end of the year."

- Reuters


Read News24’s Comments Policy

Comment on this story
Comments have been closed for this article.

Read more from our Users

Nigeria @ 56: Words to my green f...

A leader’s job is not to dictate, but rather to be respected, admired and be a trustee, of the land we love, with so much potential, a land which should be freer than free. Its still a long way to fufilling our destiny! Read more...

Submitted by
Isaac Asabor263
Recession: An opportunity for Nig...

The recession should be seen as an opportunity for the country’s promotion as long as we all collectively conduct ourselves in a patriotic manner, writes Isaac Asabor.  Read more...

Submitted by
Black and White

We want to imitate the whites in everything because we are ignorant of our inherent originality and content. We spend all our Naira to acquire his inventions because we so oblivious of our natural endowments that we allow him have it for free. Read more...

Submitted by
Nate Nat
Adamawa State University Mubi: A ...

ADSU integrity forum has accused the Sunday Joshua Wugira, a lawyer, of adopting unorthodox tactics by abusing his privilege by attacking the integrity of ADSU Vice Chancellor Dr. Moses Zira Zaruwa, writes a News24 reader. Read more...

Submitted by
Abdulsalam Jubril
My Country Nigeria (Part One)

Poetry by Abdulsalam Jubril.

Submitted by
Abdulsalam Jubril
Recession, dearth in leadership a...

Every leader has the opportunity to become great and making himself immortal in the lives and hearts of people for generations to come. Will Mr. President seize this opportunity?, questions Abdulsalam Jubril. Read more...